Discard the top 3 cards of your deck. If any of those cards are Energy cards, attach them to this Pokémon.
Discard all basic Fire Energy or all basic Lightning Energy attached to this Pokémon. This attack does 60 damage times the number of Energy you discarded.
Dragons Exalted entered circulation in 2012. Dragons Exalted is grouped under the Black & White era.
With 128 listed cards, this is a mid-size set by modern TCG standards. As of 2026, the set is 14 years old and fits a legacy-era profile.
Within this set, Rayquaza-EX is card number 123 with a Rare Ultra designation.
Rayquaza-EX appears in Dragons Exalted, released in 2012. Its card type is Pokémon.
The rarity label is Rare Ultra. Printed HP is 170.
Energy typing is Dragon. This gives collectors a clear identity footprint for the print.
Card subtype classification is Basic and EX. Card rules text: Pokémon-EX rule: When a Pokémon-EX has been Knocked Out, your opponent takes 2 Prize cards.
Current market pricing for Rayquaza-EX (Dragons Exalted) sits near $48.00. The 7-day delta remains near neutral at 0.0%.
That is close to the 30-day average of $48.00. Across the past 90 days, tracked prices have stayed near $48.00 with minimal dispersion.
The listed rarity for this print is Rare Ultra.
Other Rayquaza-EX printings create a useful comparison set for Rayquaza-EX. The current sample spans 6 comparable cards from 2 sets.
Comparable prices currently cover $18.17-$127.25, a 600% band. Against the sample mean of $53.39, this card is -10%.
Notable alternatives include Rayquaza-EX #XY66 (XY Black Star Promos) at $34.79, Rayquaza-EX #XY69 (XY Black Star Promos) at $98.05, Rayquaza-EX #XY73 (XY Black Star Promos) at $18.17, and Rayquaza-EX #60 (Roaring Skies) at $20.08.
Collector-focused market read: Short-term movement is stable (0.0% over 7 days), with price action clustered near recent averages. With a 0% 90-day spread ($48.00-$48.00), this card currently tracks as low-volatility.
Current value remains close to its 30-day mean ($48.00). Graded comparison currently centers on PSA 9 near $2153.47, representing +4386% over raw value.
